Back to today’s briefing

Story perspectives

FDA Launches Investigation into Mifepristone's Safety Amid Controversy

6/5/2025

47 8

Summary

Story summary

Amid rising legal battles, FDA Commissioner Marty Makary has launched an investigation into the safety of mifepristone, a vital medication for abortions. Senator Josh Hawley is calling for a closer look at new data indicating increased adverse events. With mifepristone accounting for 63% of U.S. abortions in 2023, its future hangs in the balance.

1 of 1

Story summary

Amid rising legal battles, FDA Commissioner Marty Makary has launched an investigation into the safety of mifepristone, a vital medication for abortions. Senator Josh Hawley is calling for a closer look at new data indicating increased adverse events. With mifepristone accounting for 63% of U.S. abortions in 2023, its future hangs in the balance.